Stockscreener 앱 받기
34.13
1.16%
-0.40
시간 외 거래:
34.00
-0.13
-0.38%
전일 마감가:
$34.53
열려 있는:
$33.99
하루 거래량:
2.27M
Relative Volume:
1.02
시가총액:
$3.04B
수익:
$333.87M
순이익/손실:
$-169.00M
주가수익비율:
-16.73
EPS:
-2.04
순현금흐름:
$-157.30M
1주 성능:
+14.49%
1개월 성능:
+38.51%
6개월 성능:
+61.37%
1년 성능:
+88.56%
1일 변동 폭
$33.58
$36.15
1주일 범위
$29.49
$36.15
52주 변동 폭
$12.91
$36.15
Travere Therapeutics Inc Stock (TVTX) Company Profile
명칭
Travere Therapeutics Inc
전화
888-969-7879
주소
3611 VALLEY CENTRE DR, SAN DIEGO
TVTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TVTX
Travere Therapeutics Inc
|
34.13 | 3.09B | 333.87M | -169.00M | -157.30M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Travere Therapeutics Inc Stock (TVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 재확인 | Citigroup | Buy |
| 2025-06-11 | 재확인 | Citigroup | Buy |
| 2025-06-11 | 재개 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-21 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-09 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-03-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-12-05 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-11-20 | 개시 | Citigroup | Neutral |
| 2023-09-22 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-09-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-09-06 | 재개 | Evercore ISI | Outperform |
| 2023-07-21 | 개시 | JP Morgan | Overweight |
| 2023-06-07 | 재개 | Piper Sandler | Neutral |
| 2023-05-22 | 개시 | TD Cowen | Outperform |
| 2023-05-05 | 업그레이드 | Bryan Garnier | Sell → Neutral |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-21 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-12-14 | 개시 | Stifel | Hold |
| 2022-12-05 | 개시 | Wells Fargo | Overweight |
| 2022-09-21 | 개시 | Bryan Garnier | Sell |
| 2022-07-14 | 재개 | Canaccord Genuity | Buy |
| 2022-03-31 | 개시 | Piper Sandler | Overweight |
| 2022-02-28 | 개시 | H.C. Wainwright | Buy |
| 2021-05-26 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Travere Therapeutics Inc 주식(TVTX)의 최신 뉴스
Travere Therapeutics to Participate at Upcoming Investor Conferences - The Joplin Globe
Travere Therapeutics (NASDAQ: TVTX) to present at Nov–Dec 2025 conferences; webcasts - Stock Titan
Insider Sell Alert: Peter Heerma Sells Shares of Travere Therape - GuruFocus
TVTX Target Price Raised to $35.00 by Piper Sandler on Neutral R - GuruFocus
How Travere Therapeutics Inc. stock compares to industry benchmarks2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
Backtesting results for Travere Therapeutics Inc. trading strategies2025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
168,000 Shares in Travere Therapeutics, Inc. $TVTX Bought by Hussman Strategic Advisors Inc. - MarketBeat
Can Travere Therapeutics Inc. stock maintain growth trajectoryEntry Point & Safe Capital Growth Trade Ideas - newser.com
Can Travere Therapeutics Inc. stock outperform in 2025 bull marketWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Real time scanner hits for Travere Therapeutics Inc. explainedPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
What makes Travere Therapeutics Inc. stock attractive to growth fundsRecession Risk & Weekly High Return Forecasts - newser.com
Pattern recognition hints at Travere Therapeutics Inc. upside2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
How geopolitical tensions affect Travere Therapeutics Inc. stockIPO Watch & Long-Term Investment Growth Plans - newser.com
Travere Therapeutics (TVTX) Climbs 25% on Impressive Earnings - MSN
Does Travere Therapeutics Inc. show high probability of reboundJuly 2025 Short Interest & Low Risk High Win Rate Picks - newser.com
Detecting support and resistance levels for Travere Therapeutics Inc.July 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Will Travere Therapeutics Inc. stock gain from strong economyJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Can Travere Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Market Mood & Advanced Technical Analysis Signals - newser.com
Results: Travere Therapeutics, Inc. Exceeded Expectations And The Consensus Lifted Next Year's Outlook - Yahoo Finance
What recovery options are there for Travere Therapeutics Inc.Take Profit & Weekly Breakout Stock Alerts - newser.com
Can Travere Therapeutics Inc. stock hit analyst price targetsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Cantor Fitzgerald Issues Negative Estimate for TVTX Earnings - MarketBeat
Will Travere Therapeutics Inc. stock outperform international peersEarnings Growth Summary & Weekly Hot Stock Watchlists - newser.com
What momentum shifts mean for Travere Therapeutics Inc.July 2025 Summary & Accurate Technical Buy Alerts - newser.com
How moving averages guide Travere Therapeutics Inc. tradingMarket Performance Summary & Precise Swing Trade Alerts - newser.com
Travere Therapeutics (TVTX) Hits Fresh High on Impressive Earnings, Bullish Outlook - MSN
What indicators show strength in Travere Therapeutics Inc.July 2025 Institutional & Long-Term Investment Growth Plans - newser.com
When is the best time to exit Travere Therapeutics Inc.CEO Change & Free High Return Stock Watch Alerts - newser.com
Travere Therapeutics Stock (TVTX) Opinions on Q3 Earnings Surge - Quiver Quantitative
Jennison Associates LLC Sells 80,602 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics Reports Strong Q3 2025 Growth - MSN
10 Stocks With Easy 20-40% Gains - Insider Monkey
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2025 Earnings Call Transcript - Insider Monkey
TD Cowen Forecasts Strong Price Appreciation for Travere Therapeutics (NASDAQ:TVTX) Stock - MarketBeat
Why Travere Therapeutics Inc. stock could outperform in 2025Market Trend Report & Reliable Price Breakout Alerts - newser.com
Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
A Look at Travere Therapeutics's Valuation Following Strong Q3 Profit and FILSPARI Momentum - Yahoo Finance
Travere Therapeutics (NASDAQ:TVTX) Reaches New 1-Year High Following Earnings Beat - MarketBeat
Travere Therapeutics (TVTX) Is Up 25.3% After FILSPARI Drives Q3 Profit Turnaround and Global Milestone - Yahoo Finance
Travere Therapeutics stock hits 52-week high at 33.66 USD By Investing.com - Investing.com Australia
Travere Therapeutics Inc (TVTX) Stock Price, Trades & News - GuruFocus
TD Cowen Maintains Travere Therapeutics (TVTX) Buy Recommendation - MSN
Travere Therapeutics (TVTX): Unprofitable But Forecast 67% Annual Earnings Growth Challenges Bearish Narratives - Yahoo Finance
Travere Therapeutics Inc (TVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):